Clinical Trials in Chicago

Showing 6341-6360 of 20,493 trials

Intermediate Expanded Access Protocol CNMAu8.EAP04

NCT06408727

An Intermediate Expanded Access Protocol (EAP) with CNM-Au8 for Amyotrophic Lateral Sclerosis for NIH Grant RFA-NS-23-012

ALSAmyotrophic Lateral SclerosisPALS

Clene Nanomedicine

Fort Lauderdale, Florida, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +5 more locations

COMPLETEDPhase 22.2 miles

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis

NCT04490109

This is a double-blind, randomized, vehicle-controlled study to assess the efficacy, safety, and tolerability of 2 doses of B244 for the treatment of pruritus in adults with a history of atopic dermatitis. Subjects who meet the study entry criteria will be randomized in a 1:1:1 ratio to receive twice daily topical doses of B244 O.D. 5.0, B244 O.D. 20.0, or vehicle (placebo) for 4 weeks.

Atopic DermatitisPruritus

AOBiome LLC547 participantsStarted Jun 2020

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +53 more locations

Intermediate Expanded Access Protocol CNMAu8.EAP04

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis

Find Trials by Condition in Chicago

A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)

BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

FemBloc® Permanent Contraception - Confirmation Feasibility Trial

Self-Assembling Matrix Forming Gel to Prevent Stricture Formation

A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Multi-Center Study on Performance of the Ponto Implant System Using Minimally Invasive Ponto Surgery (in Adult Patients)

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.

Prospective Research in Infants With Mild Encephalopathy

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML

RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)